Acquisitions was the Key Growth Strategies Adopted by Players in the Global Transfer Membrane Market
The global transfer membrane market is projected to reach 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5%. Factors such as increasing public and private funding for life science research, the significantly high prevalence of target diseases across the globe, and increasing R&D spending by pharmaceutical and biotechnology companies are expected to propel the growth of transfer membrane market. As of 2017, some of the prominent players in the transfer membrane market were Merck KGaA (US), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), GE Healthcare (US), PerkinElmer (US), Pall Coporation (US), Advansta (US), GVS (Italy), Santa Cruz Biotechnology (US), Abcam (UK), ATTO Corporation (Japan), Carl Roth (Germany), Macherey-Nagel (Germany), Azure Biosystems (US), and Axiva Sichem Biotech (India),. Analysis of the developments in transfer membrane market during period of 2015 and 2018 shows that acquisitions was the most widely adopted growth strateg...